TRANSCODE THERAPEUTICS Trademark

Trademark Overview


On Wednesday, October 20, 2021, a trademark application was filed for TRANSCODE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TRANSCODE THERAPEUTICS trademark a serial number of 97083236. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, November 13, 2023. This trademark is owned by TransCode Therapeutics, Inc.. The TRANSCODE THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer; diagnostic preparations for medical purposes
transcode therapeutics

General Information


Serial Number97083236
Word MarkTRANSCODE THERAPEUTICS
Filing DateWednesday, October 20, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, November 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancer; diagnostic preparations for medical purposes
Pseudo MarkTRANS CODE THERAPEUTICS
Disclaimer with Predetermined Text"THERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTransCode Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02109

Party NameTransCode Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02109

Trademark Events


Event DateEvent Description
Wednesday, November 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 13, 2023SOU EXTENSION 1 GRANTED
Monday, November 13, 2023SOU EXTENSION 1 FILED
Monday, November 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 30, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, February 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, February 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 4, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 4, 2022NON-FINAL ACTION E-MAILED
Thursday, August 4, 2022NON-FINAL ACTION WRITTEN
Wednesday, July 27, 2022ASSIGNED TO EXAMINER
Friday, November 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 23, 2021NEW APPLICATION ENTERED